This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stone, G. W.
Right arrow Articles by Kornbluth, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stone, G. W.
Right arrow Articles by Kornbluth, R. S.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, November 2006, p. 1223-1230, Vol. 13, No. 11
1071-412X/06/$08.00+0     doi:10.1128/CVI.00198-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Macaque Multimeric Soluble CD40 Ligand and GITR Ligand Constructs Are Immunostimulatory Molecules In Vitro{triangledown}

Geoffrey W. Stone,1,2,3,{dagger} Suzanne Barzee,1,{dagger} Victoria Snarsky,1 Celsa A. Spina,2,3 Jeffrey D. Lifson,4 Vinod Kumar Bhaskara Pillai,5 Rama Rao Amara,5 François Villinger,6 and Richard S. Kornbluth1,3*

Department of Medicine,1 Department of Pathology, University of California, San Diego, 9500 Gilman Drive #0679, La Jolla, California,2 VA San Diego Healthcare System, 3350 La Jolla Village Dr., La Jolla, California,3 AIDS Vaccine Program, Inc., SAIC Frederick, National Cancer Institute at Frederick, Frederick, Maryland,4 Department of Microbiology and Immunology, Emory Vaccine Center and Yerkes National Primate Research Center, Emory University School of Medicine, Atlanta, Georgia,5 Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia6

Received 31 May 2006/ Returned for modification 14 July 2006/ Accepted 28 August 2006

CD40 ligand (CD40L) and GITR ligand (glucocorticoid-induced tumor necrosis factor receptor-related protein ligand [GITRL]) are tumor necrosis factor superfamily molecules that can be used as vaccine adjuvants. In a previous human immunodeficiency virus (HIV) DNA vaccine study in mice, we found that plasmids expressing multimeric soluble forms of trimeric CD40L (i.e., many trimers) were stronger activators of CD8+ T-cell responses than were single-trimer soluble forms or the natural membrane-bound molecule. This report describes similar multimeric soluble molecules that were constructed for studies in macaques. Both two-trimer and four-trimer forms of macaque CD40L were active in B-cell proliferation assays using macaque and human cells. With human cells, four-trimer macaque GITRL costimulated CD4+ T-cell proliferation and abrogated the immunosuppressive effects of CD4+ CD25+ regulatory T cells on a mixed leukocyte reaction. These molecular adjuvants provide new tools for vaccine development in the simian immunodeficiency virus system and other macaque models.

* Corresponding author. Mailing address: Stein Clinical Sciences Bldg., Room 304, University of California, San Diego, 9500 Gilman Drive #0679, La Jolla, CA 92093-0679. Phone: (858) 552-8585, ext. 2620. Fax: (858) 552-7445. E-mail: rkornbluth{at}ucsd.edu.

{triangledown} Published ahead of print on 20 September 2006.

{dagger} G.W.S. and S.B. contributed equally to this paper.

Clinical and Vaccine Immunology, November 2006, p. 1223-1230, Vol. 13, No. 11
1071-412X/06/$08.00+0     doi:10.1128/CVI.00198-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Schoenly, K. A., Weiner, D. B. (2008). Human Immunodeficiency Virus Type 1 Vaccine Development: Recent Advances in the Cytotoxic T-Lymphocyte Platform "Spotty Business". J. Virol. 82: 3166-3180 [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»